Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infection (ABSSSI) in Patients with Diabetes Mellitus

BACKGROUND: ABSSSIs are common in patients with diabetes and have an increased risk of complications. Dalbavancin is a long-acting lipoglycopeptide with potent activity against Gram-positive pathogens responsible for ABSSSI, including methicillin-resistant Staphylococcus aureus (MRSA), and has demon...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowak, Michael, Rappo, Urania, Gonzalez, Pedro L, Chen, Jie, McGregor, Jennifer S, Bryowsky, Jason, Talan, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632173/
http://dx.doi.org/10.1093/ofid/ofx163.068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632173/
http://dx.doi.org/10.1093/ofid/ofx163.068

Ejemplares similares